The standard 3 h breath hydrogen (3hBH2) test distinguishes lactose maldigesters from lactose digesters. However, multiple factors impact on BH2 and care is needed to exclude a priori variables. When these factors are controlled, a negative BH2 test implies lactase persistent status or lactase nonpersistent status with colonic adaptation. A case of a Sicilian man who tested negative (lactase persistent status confirmed) on an initial 50 g lactose challenge is described. It was observed that he consumed 28.1 g lactose/day before testing. He subsequently underwent five additional challenge tests in the course of the next 10 months. In four tests the dose intake of lactose was varied upon instruction, and in the fifth test a 30 g lactulose challenge was carried out. It was demonstrated that on radically decreasing lactose intake, a full lactase nonpersistent status was unmasked. Output of 3hBH2 varied inversely with daily lactose intake. Finally, at a time when he was readapted to lactose, there was no discernible adaptation to lactulose challenge. It was concluded that 'occult' colonically adapted subjects may contribute to negative BH2 tests. There is a relationship between variation in lactose intake and the results of BH2 testing. Finally, there was no cross-adaptation to lactulose challenge when lactose was used as the adapting sugar.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1155/2004/763529 | DOI Listing |
Metab Brain Dis
December 2024
Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.
Hepatic encephalopathy (HE) is a critical neuropsychiatric complication of liver cirrhosis with a significant impact on patient quality of life and survival. The global prevalence of cirrhosis and associated HE necessitates a comprehensive understanding of the condition and effective systems of care to optimize outcomes. This review addresses the epidemiology, classification, diagnosis, and management of HE, with an emphasis on systems of care that improve outcomes for people with HE.
View Article and Find Full Text PDFExpert Opin Investig Drugs
December 2024
SeLiver Group at Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, Seville, Spain.
Introduction: Hepatic encephalopathy (HE) presents a complex pathophysiology, creating multiple potential treatment avenues. This review covers current and emerging treatments for HE.
Areas Covered: Standard therapies, including non-absorbable disaccharides and rifaximin, are widely used but show inconsistent efficacy.
Cureus
October 2024
Department of General and Family Medicine, Fujita Health University, Toyoake, JPN.
Hepatic encephalopathy (HE) is a neurological impairment that typically occurs in patients with liver dysfunction or portosystemic shunting. Diagnosing HE can be challenging since it requires a process of exclusion. Ammonia is considered a major contributor to HE, though ruling out HE solely based on ammonia levels has the potential for misdiagnosis.
View Article and Find Full Text PDFIndian J Nephrol
May 2024
Division of Paediatric Nephrology, Okinawa Prefectural Nanbu Medical Centre, Children's Medical Centre, Haebaru, Japan.
Small intestinal bacterial overgrowth (SIBO) is a clinical syndrome involving gastrointestinal symptoms caused by the presence of excessive bacteria in the small intestine. SIBO often leads to diarrhea and poses diagnostic and treatment challenges. Here, we report about a renal transplant recipient who experienced diarrhea-induced hypovolemic shock due to SIBO, necessitating the reintroduction of dialysis, and aim to provide insights to aid health-care providers in diagnosing and managing severe diarrhea in this specific patient group.
View Article and Find Full Text PDFAm J Clin Nutr
September 2024
Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, United States. Electronic address:
Background: Validated biomarkers could catalyze environmental enteric dysfunction (EED) research.
Objectives: Leveraging an EED histology scoring system, this multicountry analysis examined biomarker associations with duodenal histology features among children with EED. We also examined differences in 2-h compared with 1-h urine collections in the lactulose rhamnose (LR) dual sugar test.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!